Hetrombopag olamine+standard therapy    (DrugBank: Hetrombopag)

1 disease
IDDisease name (Link within this page)Number of trials
60Aplastic anemia1

60. Aplastic anemia    [ 218 clinical trials,   362 drugs,   (DrugBank: 81 drugs),   39 drug target genes,   155 drug target pathways]
Searched query = "Aplastic anemia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 218 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03825744
(ClinicalTrials.gov)
March 5, 201930/1/2019Hetrombopag or Placebo in Treatment-Naive Severe Aplastic AnemiaA Phase III Multicenter Randomized Study of Hetrombopag or Placebo in Treatment-Naive Severe Aplastic AnemiaSevere Aplastic AnemiaDrug: Hetrombopag Olamine+Standard Therapy;Drug: Placebo+Standard TherapyJiangsu HengRui Medicine Co., Ltd.NULLRecruiting15 Years75 YearsAll180Phase 3China